Correlation Between Snap and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Snap and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Snap and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Snap Inc and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Snap and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Snap with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Snap and NLS Pharmaceutics.
Diversification Opportunities for Snap and NLS Pharmaceutics
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Snap and NLS is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Snap Inc and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Snap is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Snap Inc are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Snap i.e., Snap and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Snap and NLS Pharmaceutics
Given the investment horizon of 90 days Snap Inc is expected to under-perform the NLS Pharmaceutics. But the stock apears to be less risky and, when comparing its historical volatility, Snap Inc is 7.75 times less risky than NLS Pharmaceutics. The stock trades about -0.03 of its potential returns per unit of risk. The NLS Pharmaceutics AG is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1.50 in NLS Pharmaceutics AG on September 1, 2024 and sell it today you would lose (0.50) from holding NLS Pharmaceutics AG or give up 33.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Snap Inc vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| Snap Inc |
| NLS Pharmaceutics |
Snap and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Snap and NLS Pharmaceutics
The main advantage of trading using opposite Snap and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Snap position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.The idea behind Snap Inc and NLS Pharmaceutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| NLS Pharmaceutics vs. Reviva Pharmaceuticals Holdings | NLS Pharmaceutics vs. GeoVax Labs | NLS Pharmaceutics vs. NLS Pharmaceutics AG | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stocks Directory Find actively traded stocks across global markets |